Your browser doesn't support javascript.
loading
[The prevalence of the Cys282Tyr mutation in the hemochromatosis gene in Cantabria in patients diagnosed with hereditary hemochromatosis]. / Prevalencia de la mutación Cys282Tyr del gen de la hemocromatosis en Cantabria y en los pacientes diagnosticados de hemocromatosis hereditaria.
Fábrega, E; Castro, B; Sánchez-Castro, L; Benito, A; Fernández-Luna, J L; Pons-Romero, F.
Afiliação
  • Fábrega E; Servicio de Aparato Digestivo, Hospital Universitario Marqués de Valdecilla, Santander.
Med Clin (Barc) ; 112(12): 451-3, 1999 Apr 10.
Article em Es | MEDLINE | ID: mdl-10320958
ABSTRACT

BACKGROUND:

The aim of our study was to evaluate the prevalence of Cys282Tyr mutation in patients with genetic haemochromatosis (GH) in Cantabria. PATIENTS AND

METHODS:

The HFE Cys282Tyr mutation was determined in a cohort of 60 patients with GH and 213 controls.

RESULTS:

The frequency of the Cys282Tyr mutation in control individuals was 4.4%. Sixty-seven percent of patients with GH were homozygous for the Cys282Tyr mutation. Twenty-seven percent of patients were normal at Cys282Tyr loci.

CONCLUSIONS:

The prevalence of the Cys282Tyr mutation in patients with GH in Cantabria, Spain, seems to be lower than in North America and in North Europe patients.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Tirosina / Cisteína / Hemocromatose / Mutação Idioma: Es Ano de publicação: 1999 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Tirosina / Cisteína / Hemocromatose / Mutação Idioma: Es Ano de publicação: 1999 Tipo de documento: Article